Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses.
Taghreed HirzShenglin MeiHirak SarkarYoumna KfouryShulin WuBronte M VerhoevenAlexander O SubtelnyDimitar V ZlatevMatthew W WszolekKeyan SalariEvan MurrayFei ChenEvan Z MacoskoChin-Lee WuDavid T ScaddenDouglas M DahlNinib BaryawnoPhilip J SaylorPeter V KharchenkoDavid Brian SykesPublished in: Nature communications (2023)
The treatment of low-risk primary prostate cancer entails active surveillance only, while high-risk disease requires multimodal treatment including surgery, radiation therapy, and hormonal therapy. Recurrence and development of metastatic disease remains a clinical problem, without a clear understanding of what drives immune escape and tumor progression. Here, we comprehensively describe the tumor microenvironment of localized prostate cancer in comparison with adjacent normal samples and healthy controls. Single-cell RNA sequencing and high-resolution spatial transcriptomic analyses reveal tumor context dependent changes in gene expression. Our data indicate that an immune suppressive tumor microenvironment associates with suppressive myeloid populations and exhausted T-cells, in addition to high stromal angiogenic activity. We infer cell-to-cell relationships from high throughput ligand-receptor interaction measurements within undissociated tissue sections. Our work thus provides a highly detailed and comprehensive resource of the prostate tumor microenvironment as well as tumor-stromal cell interactions.
Keyphrases
- single cell
- prostate cancer
- rna seq
- high throughput
- gene expression
- radiation therapy
- high resolution
- radical prostatectomy
- bone marrow
- squamous cell carcinoma
- small cell lung cancer
- endothelial cells
- minimally invasive
- dna methylation
- type diabetes
- stem cells
- replacement therapy
- acute coronary syndrome
- electronic health record
- benign prostatic hyperplasia
- locally advanced
- metabolic syndrome
- pain management
- rectal cancer
- induced pluripotent stem cells
- liquid chromatography